
    
      The investigators would evaluate the effects of the novel method, HTEA on cardiac function in
      the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial
      infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP
      level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks
      after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization
      would also calculated 3 months after discharge.
    
  